Stocklytics Platform
Asset logo for symbol LYRA
Lyra Therapeutics
LYRA56
$0.09arrow_drop_up1.62%$0.00
Penny Stock
Asset logo for symbol LYRA
LYRA56

$0.09

arrow_drop_up1.62%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Lyra Therapeutics (LYRA) Stocklytics Forecast

According to our AI and machine learning algorithms, the price of Lyra Therapeutics Inc (LYRA) stock is expected to experience a positive trend in the coming years. Our price prediction for LYRA suggests that the stock will gradually increase in value, reaching a new peak by 2023. Based on historical data and market trends, it is projected that LYRA stock will have a steady growth trajectory over the next few years.
Analysts also have a positive outlook for Lyra Therapeutics Inc (LYRA) stock. According to their price target projections, LYRA is expected to perform well in the long term, with a significant increase in value by 2023. The consensus among analysts is that LYRA stock is a good buy, indicating a favorable investment opportunity for potential investors. The analyst ratings for LYRA are generally positive, further supporting the optimistic outlook for the stock.
add Lyra Therapeutics  to watchlist

Keep an eye on Lyra Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Lyra Therapeutics (LYRA) stock?

Analysts have set a target price of $11.5 for Lyra Therapeutics (LYRA), based on forecasts from 11 analysts. The predicted price range extends from a high of $20 to a low of $0.5. This represents a potential increase of up to 21.64K% and a decrease of 443.48% from the current price of $0.09. These forecasts are as of 2020 May 26.
help

What are the analyst ratings for Lyra Therapeutics (LYRA) stock?

Currently, there are no analyst ratings available for Lyra Therapeutics (LYRA), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Lyra Therapeutics (LYRA) stock?

At present, there is no AI or machine-learning-based price prediction available for Lyra Therapeutics (LYRA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level